Procurement Summary
Country: Germany
Summary: Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Adefovir Dipivoxil
Deadline: 10 Sep 2025
Posting Date: 04 Oct 2023
Other Information
Notice Type: Tender
TOT Ref.No.: 89944653
Document Ref. No.: 596816-2023
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
CPV Classification
33600000 - Pharmaceutical products
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
§130a Paragraph 8 SGB V enables health insurance companies (KK) and pharmaceutical companies to conclude framework discount agreements for the medicines to be supplied at the expense of the statutory KK. The GWQ is a society for efficiency and quality at KK in accordance with Section 130a Paragraph 8 Sentence 5 SGB V for its employeestionary and customer cash registers. With regard to the relevant legal regulations for the awarding of public contracts, a regular process of active ingredient-related, formal procurement procedures takes place in accordance with the regulations of Part 4 of the GWB by GWQ ServicePlus AG. Until IWith the entry into force of new drug discount agreements, the GWQ would like to conclude drug discount agreements with all interested pharmaceutical companies as part of the open house procedure for preparations with the above-mentioned active ingredient. The earliest contract start date is November 1st, 2023.
Doc Title: Pharmaceuticalproducts
Contract Type: Supplies
Document Type : Contract notice
Reference Number : 2023/S 191-596816
Contract Type : Supplies
33600000 - Pharmaceutical products
Authority Type : Body governed by public law
Type of Procedure : Open procedure
Regulation : European Union
Bid Type : Submission for all lots
Doc Title : Pharmaceutical products
Dispatch Date : 2023-09-29
Publish Date : 2023-10-04
Submission Date : 2025-09-10
Documents
Tender Notice